Authors
Fyodorov V.E.1, Maslyakov V.V.2, Aslanov A.D.3
1 Saratov State Medical University named after V.I. Umumovsky, Saratov
2 Private institution educational organization of higher education «Saratov Medical University «Reaviz», Saratov
3 Kabardino-Balkarskiy State University named after H.M. Berbekov, Nalchik
Abstract
The work is devoted to the analysis of literary data on the analysis and structure of published clinical data, and then to describe various ways of assessing the severity of the patient taking into account comorbidity in various cohorts of patients. In the following, a brief analysis of the available scales and indices in approximation and comparison of data in surgical patients was performed on the available material.
Keywords: comorbidity, surgical diseases, severity estimates.
References
1. Pirogov NI. Sobranie sochinenij v 8 tomah. Moscow; 1962. (In Russ).
2. Oganov RG, Denisov IN, Simanenkov VI, et al. Komorbidnaja patologija v klinicheskoj praktike. Clinical recommendations. Cardiovascular therapy and prevention. 2017; 16(6): 5–56. (In Russ). doi:10.15829/1728-8800-2017-6-5-56.
3. Konev JuV. Istoricheskie osobennosti i semanticheskie trudnosti ispol’zovanija terminov, oboznachajushhih mnozhestvennost’ zabolevanij u odnogo bol’nogo. Experimental and clinical gastroenterology. 2018; 6: 4–9. (In Russ).
4. Feinstein AR. Pre-therapeutic classification of co-morbidity in chronic disease. Journal Chronic Disease. 1970; 23(7): 455–468.
5. Kraemer HC. Statistical issues in assessing comorbidity. Stat Med. 1995; 14: 721–723.
6. Van den Akker M, Buntinx F, Roos S, Knottnerus JA. Comorbidity or multimorbidity: what’s in a name? A review of the literature. Eur J Gen Pract. 1996; 2(2): 65–70.
7. Stjazhkina SN, Chernyshova TE, Ledneva AV. Komorbidnost’ v hirurgicheskoj praktike. LAP Lambert Academic Publishing; 2012: 43–44. (In Russ).
8. Stjazhkina SN, Makshakova NP, Simanova AA, et al. Rol’ komorbidnoj patologii v hirurgii. Science, education and culture. 2017; 4(19): 82–85. (In Russ).
9. Shal’nova SA, Koncevaja AM. Monitoring faktorov riska hronicheskih neinfekcionnyh zabolevanij v prakticheskom zdravoohranenii. Methodological recommendations. Moscow; 2012: 27. (In Russ). URL.
10. Mahmood S, Levy D, Vasan R, Wang T. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2013; (383): 999–1008. doi: 10.1016/S0140-6736(13)61752-3.
11. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37(29): 2315–81. doi: 10.1093/eurheartj/ehw106.
12. Stjazhkina SN, Chernyshova TE, Ledneva AV, et al. Komorbidnost’ v urgentnoj hirurgii pri gnojno-vospalitel’nyh processah brjushnoj polosti. Scientific Almanac Medical Sciences. 2016; 18(4–3): 383–383. (In Russ).
13. Centers for Medicare & Medicaid Services. Chronic conditions overview. 2014. URL.
14. Bojcov SA, Chuchalin AG. Dispansernoe nabljudenie bol’nyh hronicheskimi neinfekcionnymi zabolevanijami i pacientov s vysokim riskom ih razvitija. Methodical recommendations. Moscow, 2014. 112 р. (In Russ). URL.
15. Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018; 39(33): 3021–104. doi: 10.1093/eurheartj/ehy339.
16. Chazova IE, Mychka VB, Kisljak OA, et al. Diagnostika i lechenie metabolicheskogo sindroma. Rossijskie rekomendacii (vtoroj peresmotr). Cardiovascular therapy and prevention. 2009; 8(62): 1–29. (In Russ).
17. Сaughey GE, Vitry AI, Gilbert AL, Roughead EE. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health. 2008; 8: 221.
18. Aronow WS. Prevalence of CAD, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Card. 2000; 86: 1142–1143.
19. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in elderly. Arch Inter Med. 2002; 162: 2269–2276.
20. Oganov RG, Denisov IN, Simanenkov VI, et al. Komorbidnaja patologija v klinicheskoj praktike. Klinicheskie rekomendacii. Cardiovascular therapy and prevention. 2017; 16(6): 5–56. (In Russ). doi:10.15829/1728-8800-2017-6-5-56.
21. Oxford Centre for Evidence-Based Medicine. URL.
22. Lazebnik LB, Vertkin AL, Konev JuV, et al. Starenie: professional’nyj vrachebnyj podhod (Nacional’noe rukovodstvo). Moscow: Eksmo; 2014. 320 p. (In Russ).
23. Daveluy C, Pica L, Audet N. Enquete Sociale et de Sante 1998. 2 nd ed. Quebec: Institut de la statistique du Quebec; 2001.
24. Vjortkin AL, Skotnikov AS. Komorbidnost’. Attending physician. 2013; 6: 26. (In Russ).
25. De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003; 56(3): Р. 221–229.
26. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Amer Geriatr Soc. 1968; 6: 622–626.
27. Miller MD, Towers A. Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G). Pittsburg, Pa: University of Pittsburgh; 1991.
28. Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. Journal Chronic Disease. 1974; 27: 387–404.
29. Van Weel C, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet. 2006; 367: 550–551.
30. Charlson ME, Pompei P, Ales HL. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal Chronic Disease. 1987; 40: 373–383.
31. Greenfield S, Apolone G. The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: Comorbidity and outcomes after hip replacement. Med Care. 1993; 31: 141–154.
32. Rozzini R, Frisoni GB, Ferrucci L, et al. Geriatric Index of Comorbidity: validation and comparison with other measures of comorbidity. Age Ageing. 2002; 31(4): 277–285.
33. Grolla DL, Tob T, Bombardierc C, Wright JG. The development of a comorbidity index with physical function as the outcome. Journal of Clinical Epidemiology. 2005; 58(6): 595–602.
34. Harboun M, Ankri J. Comorbidity indexes: review of the literature and application to the elderly population. Rev Epidemiol Sante Publique. 2001; 49(3): 287–298.
35. Walter LC, Brand RJ, Counsell SR, et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA. 2001; 285(23): 2987–2994.
36. Desai MM, Bogardus STJr, Williams CS, Vitagliano G, Inouye SK. Development and validation of a risk-adjustment index for older patients: the high-risk diagnoses for the elderly scale. J Am Geriatr Soc. 2002; 50: 474–481.
37. Carey EC, Walter LC, Lindquist K, Covinsky KE. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med. 2004; 10: 1027–1033.
38. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006; 295: 801–808.
39. Lazebnik LB. Polimorbidnost’ i starenie. Medicine and pharmacy news. 2007; 1: 205. (In Russ).
40. Grimby A, Svanborg A. Morbidity and health-related quality of life among ambulant elderly citizens. Aging. 1997; 9: 56–364.
41. Hudon C, Fortin M, Lapointe L, Vanasse A. Multimorbidity in medical literature: Is it commonly researched? Can Fam Physician. 2005; 51: 244–245.
42. Nurgazizova A.K. Proishozhdenie, razvitie i sovremennaja traktovka ponjatij «Komorbidnost’» i «Polimorbidnost’». Kazan Medical Journal. 2014; 95(2): 292–296. (In Russ).
